INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines – AVXL
Pomerantz Law Firm has filed class action lawsuits against Anavex Life Sciences Corp. (AVXL) for alleged securities fraud and unlawful business practices. The lawsuit follows the May 2026 termination of CEO Christopher Missling and an August 2026 disclosure of material weaknesses in internal controls. Investors have until November 30, 2026, to join as lead plaintiffs.


